CSL Limited (CMXHF)
OTCMKTS · Delayed Price · Currency is USD
125.71
+0.71 (0.57%)
Jan 28, 2026, 9:30 AM EST
CSL Limited Employees
CSL Limited had 29,904 employees as of June 30, 2025. The number of employees decreased by 2,794 or -8.54% compared to the previous year.
Employees
29,904
Change (1Y)
-2,794
Growth (1Y)
-8.54%
Revenue / Employee
$520,265
Profits / Employee
$100,388
Market Cap
60.46B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 29,904 | -2,794 | -8.54% |
| Jun 30, 2024 | 32,698 | 633 | 1.97% |
| Jun 30, 2023 | 32,065 | 2,065 | 6.88% |
| Jun 30, 2022 | 30,000 | 5,000 | 20.00% |
| Jun 30, 2021 | 25,000 | -2,000 | -7.41% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
CSL Limited News
- 1 day ago - CSL Limited: Upside Potential Is Strong From These Levels But I Remain Cautious - Seeking Alpha
- 2 days ago - Deutsche Bank Appointed as Successor Depositary Bank for the American Depositary Receipt Program of CSL Limited - Business Wire
- 7 weeks ago - Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years - PRNewsWire
- 2 months ago - CSL Limited (CSLLY) Commits $1.5B to Expand U.S. Operations - GuruFocus
- 2 months ago - Australian biotech CSL announces $1.5B investment in the U.S. - Seeking Alpha
- 3 months ago - CSL Limited (CSLLY) Analyst/Investor Day Prepared Remarks Transcript - Seeking Alpha
- 3 months ago - CSL Limited (CSLLY) Shareholder/Analyst Call Transcript - Seeking Alpha
- 3 months ago - CSL Limited (CSLLY) Shareholder/Analyst Call - Slideshow - Seeking Alpha